These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24015976)

  • 21. Molecular insights into the inhibitory mechanisms of gallate moiety on the Aβ
    Nie RZ; Huo YQ; Yu B; Liu CJ; Zhou R; Bao HH; Tang SW
    Int J Biol Macromol; 2020 Aug; 156():40-50. PubMed ID: 32275992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).
    Kai T; Zhang L; Wang X; Jing A; Zhao B; Yu X; Zheng J; Zhou F
    ACS Chem Neurosci; 2015 Jun; 6(6):879-88. PubMed ID: 25874995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular insights into the effect L17A/F19A double mutation on the structure and dynamics of Aβ
    Saini RK; Shuaib S; Goyal D; Goyal B
    J Cell Biochem; 2018 Nov; 119(11):8949-8961. PubMed ID: 30076733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment.
    Xie L; Luo Y; Lin D; Xi W; Yang X; Wei G
    Nanoscale; 2014 Aug; 6(16):9752-62. PubMed ID: 25004796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation.
    Sahoo BR; Genjo T; Cox SJ; Stoddard AK; Anantharamaiah GM; Fierke C; Ramamoorthy A
    J Mol Biol; 2018 Oct; 430(21):4230-4244. PubMed ID: 30170005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity.
    Andreetto E; Yan LM; Caporale A; Kapurniotu A
    Chembiochem; 2011 Jun; 12(9):1313-22. PubMed ID: 21630409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme prevents amyloid beta peptide aggregation through hydrophobic interaction based on molecular dynamics simulation.
    Zhao LN; Mu Y; Chew LY
    Phys Chem Chem Phys; 2013 Sep; 15(33):14098-106. PubMed ID: 23868536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide backbone modifications of amyloid β (1-40) impact fibrillation behavior and neuronal toxicity.
    Schwarze B; Korn A; Höfling C; Zeitschel U; Krueger M; Roßner S; Huster D
    Sci Rep; 2021 Dec; 11(1):23767. PubMed ID: 34887476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing aggregation and fibril formation of insulin in polyelectrolyte multilayers.
    Koo J; Czeslik C
    Colloids Surf B Biointerfaces; 2012 Jun; 94():80-8. PubMed ID: 22369752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.
    Brown AM; Lemkul JA; Schaum N; Bevan DR
    Arch Biochem Biophys; 2014 Mar; 545():44-52. PubMed ID: 24418316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective antibody precipitation using polyelectrolytes: a novel approach to the purification of monoclonal antibodies.
    McDonald P; Victa C; Carter-Franklin JN; Fahrner R
    Biotechnol Bioeng; 2009 Mar; 102(4):1141-51. PubMed ID: 19031425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of polyunsaturated fatty acids with amyloid peptides Aβ40 and Aβ42.
    El Shatshat A; Pham AT; Rao PPN
    Arch Biochem Biophys; 2019 Mar; 663():34-43. PubMed ID: 30593770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zn(2+) effect on structure and residual hydrophobicity of amyloid β-peptide monomers.
    Shi H; Kang B; Lee JY
    J Phys Chem B; 2014 Sep; 118(35):10355-61. PubMed ID: 25117080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and aggregation mechanism of amyloid β-peptides onto the GM1 ganglioside-containing lipid membrane.
    Hoshino T; Mahmood MI; Mori K; Matsuzaki K
    J Phys Chem B; 2013 Jul; 117(27):8085-94. PubMed ID: 23688073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Piedmont mutation (L34V) on the structure, dynamics, and aggregation of Alzheimer's Aβ
    Saini RK; Thakur H; Goyal B
    J Mol Graph Model; 2020 Jun; 97():107571. PubMed ID: 32143150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular insight into conformational transition of amyloid β-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations.
    Liu FF; Dong XY; He L; Middelberg AP; Sun Y
    J Phys Chem B; 2011 Oct; 115(41):11879-87. PubMed ID: 21899367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of Caffeine as an Amyloid Inhibitor in the Aggregation of Aβ16-22 Peptides.
    Sharma B; Paul S
    J Phys Chem B; 2016 Sep; 120(34):9019-33. PubMed ID: 27487451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggregation of Beta-Amyloid Peptides Proximal to Zwitterionic Lipid Bilayers.
    Yang CI; Tsai BN; Huang SJ; Wang TY; Tai HC; Chan JC
    Chem Asian J; 2015 Sep; 10(9):1967-71. PubMed ID: 26097047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.